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Abstract
Background: Thoracotomy is associated with severe pain that may persist for years. Acupuncture
is a complementary therapy with a proven role in pain control. A randomized trial showed that
acupuncture was effective in controlling pain after abdominal surgery, but the efficacy of this
technique for the treatment of thoracotomy pain has not been established. We developed a novel
technique for convenient application of acupuncture to patients undergoing thoracotomy, and in a
Phase II trial evaluated the safety of this intervention and the feasibility of doing a randomized trial.
Methods:  Adult patients scheduled for unilateral thoracotomy with preoperative epidural
catheter placement received acupuncture immediately prior to surgery. Eighteen semi-permanent
intradermal needles were inserted on either side of the spine, and four were inserted in the legs
and auricles. Needles were removed after four weeks. Using a numerical rating scale, pain was
measured on the first five postoperative days. After discharge, pain was assessed using the Brief
Pain Inventory at 7, 30, 60 and 90 days.
Results: Thirty-six patients were treated with acupuncture. Of these, 25, 23, and 22 patients
provided data at 30, 60, and 90 days, respectively. The intervention was well tolerated by patients
with only one minor and transient adverse event of skin ulceration.
Conclusion:  The rate of data completion met our predefined criterion for determining a
randomized trial to be feasible (at least 75% of patients tolerated the intervention and provided
evaluable data). This novel intervention is acceptable to patients undergoing thoracotomy and does
not interfere with standard preoperative care. There was no evidence of important adverse events.
We are now testing the hypothesis that acupuncture significantly adds to standard perioperative
pain management in a randomized trial.
Background
Thoracotomy is a common procedure employed for pri-
mary lung cancer, with almost 30,000 performed annu-
ally in the United States (Source: Agency for Healthcare
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Research and Quality). The procedure is extensive and can
be associated with severe pain in patients already compro-
mised by numerous other co-morbidities such as chronic
obstructive pulmonary disease. Pain that limits respira-
tory function can have devastating consequences on post-
operative recovery; consequently, extensive measures such
as epidural catheters, local anesthetic infiltration and non-
steroidal-anti-inflammatory drugs (NSAIDs), are used to
maximize analgesia and minimize side effects. [1,2]. Acu-
puncture represents a modality providing analgesia with a
paucity of side effects; however, acupuncture needles can
potentially overlap with the surgical field and also ham-
per epidural catheter placement, making acupuncture
impractical. We undertook a single-arm, open-label, clin-
ical trial to assess: 1) the feasibility of employing pre-oper-
ative acupuncture needles near the operative field for
analgesia after thoracotomy, 2) the acceptance by
patient's of a non-traditional technique after receiving a
diagnosis as ominous as cancer, 3) the percentage of
patients providing evaluable pain data at the first post-
operative visit (approximately 30 days post surgery), 4)
the occurrence of any adverse effects, 5) to determine the
optimal primary outcome and timepoint for the rand-
omized trial, 6) to provide data to determine sample size
calculations. With respect to the primary aim, the trial was
considered "feasible" if at least 75% of patients tolerated
the intervention; if the intervention did not interfere with
surgery and routine post-operative care; if at least 75% of
patients provided evaluable data at the first post-operative
visit; and, if reported adverse events were acceptable. Fur-
thermore, accrual needed to be sufficiently rapid so that,
after appropriate sample size calculations, a randomized
trial could be completed in less than two years.
Methods
The study was approved by the Institutional Review Board
(IRB) at Memorial Sloan-Kettering Cancer Center in
accordance with an assurance filed with and approved by
the Department of Health and Human Services. Written
informed consent was obtained from each participant.
Eligibility criteria
We recruited adult patients at Memorial Sloan-Kettering
Cancer Center who were scheduled to receive a unilateral,
posterolateral thoracotomy with analgesia using an epi-
dural catheter.
Patients excluded from the study were those scheduled to
undergo "hemiclamshell" or "clamshell" thoracotomy,
extrapleural pneumonectomy, or esophagectomy.
Patients who had received acupuncture within the previ-
ous six weeks, or who had heart valve dysfunction (a con-
traindication to the use of intradermal acupuncture
needles) were excluded. Patients with a coagulopathy pre-
cluding insertion of an epidural catheter were also ineligi-
ble. All of the patients entered on this study were operated
on by a single surgeon (VR), which allowed for uniformity
of surgical technique and perioperative care.
Treatment
Epidural catheters were placed in all patients in a pre-
operative holding area with all patients in the sitting posi-
tion. An iodine antiseptic was used to sterilize both the
field for epidural placement and acupuncture placement.
An 18 gauge Tuohy needle was used identify the epidural
space, typically at the level of T6–T12. After placement of
the epidural catheter, a test dose of lidocaine 1.5% and
epinephrine 1:200,000 in a volume of 2–3 ml was used to
identify accidental intrathecal or intravascular replace-
ment. If either occurred, the epidural catheter was either
replaced or the procedure aborted at the discretion of the
physician.
Eighteen semi-permanent intradermal acupuncture nee-
dles were inserted at points "BL12" to "BL19" and extra
point Wei Guan Xia Shu. These points are approximately
2.5 cm lateral to the lower border of spinous process of
the T2 – 10 vertebrae immediately after placement of the
epidural catheter (see Figure 1). Subsequently, both the
epidural catheter and acupuncture needles were covered
simultaneously by an occlusive Tegaderm™ dressing. In
addition, one needle was placed in each leg at the "ST36"
Intradermal acupunctures needles used in this study Figure 1
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point and one in each auricle at the "Shenmen" point.
This point prescription is based on that of Kotani et al.[3],
who reported a randomized trial showing that intrader-
mal needles at these points reduced pain compared to pla-
cebo. We added the "Shenmen" and "ST36" points on the
grounds that these are commonly used to treat pain.
We initially used "Japanese" style needles, as described by
Kotani et al.[3], but found these time-consuming to apply
and switched to stainless steel AcuMedic intradermal nee-
dles (AcuMedic Ltd., London, UK). These are thumbtack-
shaped and consist of a 2 mm × 0.28 mm acupuncture
needle attached to a metal ring embedded in surgical tape.
Patients underwent balanced general anesthesia primarily
with inhalational agents (typically Isoflurane). In addi-
tion, epidural analgesia was initiated in the operating
room using a continuous infusion of fentanyl (10 mcg/cc)
and bupivacaine (0.05%) at a fixed rate of 4 milliliters per
hour. Hydromorphone or morphine were chosen for the
epidural instead of fentanyl if an adverse reaction pre-
cluded the use of the latter. Of the evaluable patients, ten
were initiated on fentanyl and fifteen patients on hydro-
morphone. In addition analgesia was supplemented with
intravenous narcotics as needed. Unless contraindicated,
all patients received ketorolac 15–30 mg intravenously
prior to closure and in the post-operative period as
needed for up to 3 days. If a patient had persistent side
effects with subjective complaints of unacceptable analge-
sia, the epidural opioid was changed to either hydromor-
phone or morphine or removed entirely; nine patients
received more than one drug. Persistent hypotension was
ultimately treated by removal of the epidural local anes-
thetic.
The epidural catheter and acupuncture needles were both
removed after removal of the chest tube, typically 3 to 7
days post surgery. Patients were given oral medications
(typically oxycodone with acetaminophen) as needed to
manage any ongoing pain. All needles were replaced after
the epidural catheter was removed, typically 24 to 48
hours before discharge from the hospital. No restrictions
were placed on patients' activity level or showering.
Patients were asked to remove the leg and auricular nee-
dles a week after discharge. Needles on the back were
removed by an acupuncturist at the first follow-up visit,
usually 3 to 4 weeks postoperatively. Patients who
remained in pain at this time were offered further acu-
puncture treatment consisting of stainless steel, 15 mm ×
0.16 mm Seirin auricular needles placed bilaterally for
20–25 minutes at the "Shenmen", "brain" and "adrenal"
points in the ear. In addition, up to two needles were
placed at auricular points corresponding to the sites where
patients were experiencing most pain (e.g. chest, abdo-
men or ribs). Brief manual stimulation was used immedi-
ately after insertion. Practitioners attempted to achieve
"de qi", but this was assessed by needle sensation rather
than questioning of the patient. Following this treatment,
acupressure metal balls were applied at the same points,
and patients were taught to press each point for two min-
utes twice a day. They were also instructed to press on the
points if they experienced exacerbation of pain. The metal
balls typically remained in place for 4–7 days. These were
used in preference to intradermal needles for this stage of
treatment, when there is no further contact with an acu-
puncturist, as they do not penetrate the skin and there is
no risk of infection were the patient to forget to remove
them.
Acupuncture quality control
Immediately after each needle insertion, acupuncturists
completed an audit sheet verifying the acupuncture points
used. These records were routinely reviewed and acupunc-
turists were found to have followed the acupuncture point
prescription. Study acupuncturists are certified by the
National Certification Commission for Acupuncture and
Oriental Medicine (NCCAOM) and are licensed to prac-
tice acupuncture in New York State. They have used acu-
puncture in clinical practice for 3 – 25 years. All were
employees of the Integrative Medicine Service at Memo-
rial Sloan-Kettering Cancer Center.
Primary outcome
We specified that we would consider the trial feasible if at
least 75% of patients tolerated the intervention; if the
intervention did not interfere with surgery and routine
post-operative care; if at least 75% of patients provided
evaluable data at the first post-operative visit; and, if
reported adverse events were acceptable. We also wanted
to ensure that accrual was sufficiently rapid so that, after
appropriate sample size calculations, a randomized trial
could be completed in less than two years.
Pain assessment
Pain in the immediate postoperative period was assessed
by a 0–10 point numerical rating scale (NRS) marked "no
pain" at one end and "worst pain" at the other. Patients
were evaluated between 4:00 pm and 6:30 pm on the
evening of their surgery, at least two hours after leaving
the Operating Room. Those not leaving by 4.30 pm had
their first pain evaluation on the following day. On the
first postoperative day, patients were evaluated in the
morning and late afternoon. The first pain evaluation
assessed pain at rest, on movement and on coughing
"since you woke up from your operation." Subsequent
evaluations (post-operative days 2, 3, 4 and 5) evaluated
pain at rest, on movement and with coughing since the
previous evaluation.BMC Anesthesiology 2006, 6:5 http://www.biomedcentral.com/1471-2253/6/5
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After discharge from the hospital, pain was assessed 1
week from removal of the epidural catheter (11–18 days
after surgery) and again approximately 30, 60 and 90 days
postoperatively. The 11–18 day follow-up was conducted
by a research study assistant by telephone; all others were
conducted when patients returned for routine post-dis-
charge appointments. Pain was evaluated using the Brief
Pain Inventory (BPI), a validated pain measurement tool
that measures both the intensity of pain (sensory dimen-
sion) and interference of pain in the patient's life (reactive
dimension) [4]. Patients were also asked to report if they
experienced any pain which they attributed to their oper-
ation. The number of needles remaining in place at the
postoperative visit was recorded.
Data analysis
Data were analyzed using Stata 8.2 (Stata Corp., College
Station, TX). We chose an actual sample of 25 patients.
Our stopping rule was for the trial to cease once 25
patients had provided data at the 30 day follow-up.
Results
Patient accrual and adverse events
39 patients were accrued between August 2002 and Sep-
tember 2003. Participant flow is shown in Figure 2.
Accrual was limited for this pilot study because patients
were accrued only from a single clinician (VR) for opera-
tion on a single day of the week. Patient acceptance was
very good, with fewer than five patients refusing participa-
tion in the trial.
Twenty-five patients (64%) provided evaluable pain data
at the first post-operative visit. Seven patients were termi-
nated by investigators for protocol reasons such as the epi-
dural catheter not being used, or removed early due to
inadequate analgesia. None of these terminations would
occur in a randomized trial due to the "intent-to-treat"
principle. Of the patients who were not withdrawn, 25 of
32 provided evaluable data, a 78% data completion rate,
which meets our predefined criterion for doing a subse-
quent randomized trial. Three patients could not be con-
tacted and four withdrew, of whom one expressed distrust
of hospital staff, one reported no pain, one did not want
to deal with needles after discharge and one withdrew
without giving a reason.
Table 1 provides basic demographic information about
study participants. Most patients (62%) were women in
their 60 s, undergoing lobectomy for primary lung cancer.
More men and patients undergoing procedures other than
lobectomy dropped out of the study.
None of the remaining patients requested or required
removal of the acupuncture needles before discharge. Of
the 25 patients with 30-day data, there were no data on
needle retention for two: one patient received follow-up
care at a different institution and one was discharged
before reinsertion of needles. Of the 23 remaining
patients, 12 (52%) either retained 16 or more needles out
of 18; 4 patients (18%) retained fewer than half the nee-
dles and were thus defined as not tolerating the interven-
tion. If we include the patient who withdrew because of
complaints about the needles, 19 out of 24 patients
(79%) retained more than half the applied needles at 30
days.
Treatment was very well tolerated, with no patient com-
plaining of discomfort from the needles or the Tegaderm.
Seven adverse events were reported to the IRB of which six
had clearly had no relationship to acupuncture, such as
gastrointestinal infection. One patient was noted to have
a 1 cm diameter superficial skin ulcer at 30 day follow-up.
This was under the Tegaderm but away from the acupunc-
ture needles. The Tegaderm was removed, the ulcerated
area cleaned and Bacitracin ointment applied. The ulcera-
tion healed within four days.
After changing from the "Japanese" style to the Acumedic
needles (see Methods), we found that application of nee-
dles in the pre-operative period was rapid, and did not
interfere with routine care.
Results of pain assessment
Pain data for the immediate postoperative period are
shown in table 2; table 3 shows data for post-discharge
follow-ups. Although data from this single arm feasibility
trial does not permit assessment of the efficacy of acu-
puncture in the management of post-thoracotomy pain,
the data show decreasing severity of pain over time. The
design of this trial is unable to demonstrate that this effect
is from acupuncture as the primary aim is the feasibility of
performing acupuncture. Twenty-two of 25 patients who
provided data at day 30 also provided data at day 90, sug-
gesting the feasibility of obtaining long-term data. The
apparently higher pain scores at day 90 compared to day
60 probably do not indicate increasing pain as it is well
within typical statistical variation.
Discussion
There are multiple possible sources of post thoracotomy
pain, including the skin incision, muscle division, rib frac-
ture or resection, costochondral dislocation, neuroma for-
mation and, less commonly, infection or tumor
recurrence. Acute pain in post-operative period may lead
to chronic pain characterized as "the post-thoracotomy
pain syndrome."[5] This is defined as an aching or burn-
ing pain that persists or recurs along a thoracotomy scar
two months or more after surgery. Several studies estimate
the prevalence of short-term post thoracotomy pain at
50% to 80% [6,7]. Approximately 5% of all patientsBMC Anesthesiology 2006, 6:5 http://www.biomedcentral.com/1471-2253/6/5
Page 5 of 8
(page number not for citation purposes)
Participant flow through the trial Figure 2
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undergoing thoracotomy suffer severe or incapacitating
pain that interferes significantly with their daily activities.
After an initial decline, there is little evidence demonstrat-
ing an appreciable diminishment of post thoracotomy
pain over time. Although one study reported the preva-
lence of pain falling from 80% at 3 months post-surgery
to 61% at 1 year[8] a longitudinal study examined
patients 1 to 5 years post-surgery and found stable pain
intensity over the course of follow-up, with approximately
50% patients reporting some level of pain[9].
Absolute control of pain following thoracotomy using tra-
ditional analgesics can be associated with many side-
effects, some of which (like sedation) can have devastat-
ing consequences on patients with co-morbidities such as
lung disease and heart disease. Acupuncture is a well-
known complementary treatment for pain [10] with few
to no side effects, and data from recent meta-analyses sug-
gest that it can relieve both acute and chronic pain[11]. In
this study we employed it pre-operatively in a pre-emptive
fashion because of ease of placement compared to post-
operative placement.
Recent data suggest that acupuncture is effective in reliev-
ing pain following abdominal surgery[3]. In that study,
185 patients scheduled for surgery were randomized to
receive true or placebo acupuncture. In the true acupunc-
ture group, 5 mm semi-permanent acupuncture needles
were inserted preoperatively at 14 points in the back and
fixed in place with surgical tape. Patients assigned to the
control group had needles placed perpendicularly so that
they did not penetrate the skin. Pain control was superior
in the acupuncture group; the percentage of patients with
moderate or severe pain at rest on the day immediately
following surgery was 72% in the control group but only
47% in those receiving true acupuncture. Patients in the
acupuncture group also received approximately 25% less
morphine during the first four postoperative days than
did placebo patients.
Although these data are promising, we were concerned
that the severity and duration of pain reported after
abdominal surgery was somewhat less than is typical after
thoracotomy. We felt it would be necessary to provide
acupuncture stimulation over a longer period of time than
attempted by Kotani et al.[3] and hypothesized that 30
days would be ideal. Therefore, we inserted needles
immediately preoperatively, changed them before dis-
charge from the hospital and then did not remove them
until the first follow-up visit approximately 3 to 4 weeks
postoperatively. This entails needles being retained for
three weeks or more.
In this study, we demonstrated that a novel acupuncture
intervention was acceptable to staff and patients (aim 2).
We found no evidence of important adverse effects (aim
4). To our knowledge, this is the first reported clinical trial
to evaluate acupuncture in the management of post-tho-
racotomy pain. The acupuncture procedure took only five
minutes to complete and did not interfere with standard
preoperative care (aim 1), such as placement of the epi-
dural catheter. Although fewer patients than intended
provided follow-up data, the predicted rate of data com-
pletion for the randomized trial met our predefined crite-
rion (aim 3). We propose that the BPI pain intensity score
be used as our primary endpoint as this had the lowest
coefficient of variation (aim 5). We also propose 30 day
follow-up as the primary endpoint (aim 5). Although we
are also interested in chronic post-thoracotomy pain, this
ideal has to be considered against the potential of
increased patient drop-out over time. From these and oth-
ers' data [12], pain at 30 days appears reasonably predic-
tive of longer-term outcome.
Accrual was relatively slow because this pilot of a novel
technique accrued patients only from a single clinician, a
maximum of one day each week. To determine sample
size for the trial (aim 6) we used the mean BPI pain inten-
Table 2: Pain scores (VAS) in the immediate postoperative 
period versus post-operative day. Results are given as mean 
(SD). Not all patients reported cough. (Lower numbers indicate 
less pain)
Day Pain at rest Pain on movement Pain on cough
0 n = 8: 5 (2.39) n = 7: 5.86 (2.97) n = 4: 5.75 (4.35)
1 n = 34: 2.5 (2.15) n = 34: 4.38 (2.74) N = 31: 5.08 (2.97)
2 n = 32: 1.97 (1.86) n = 32: 3.66 (2.32) N = 22: 5.68 (2.25)
3 n = 29: 2.32 (2.25) n = 29: 4.48 (2.44) N = 20: 5.55 (2.63)
4 n = 15: 2.00 (2.00) n = 15: 3.20 (2.11) n = 8: 3.63 (3.07)
5 n = 9: 1.78 (2.22) n = 9: 4.00 (2.45) n = 5: 5.20 (2.77)
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less than 60 8 (32%) 3 (21%) 11 (28%)
60–70 12 (48%) 8 (57%) 20 (51%)
greater than 70 5 (20%) 3 (21%) 8 (21%)
Female 18 (72%) 6 (43%) 24 (62%)
Diagnosis
Primary lung cancer 23 (92%) 13 (93%) 36 (92%)
Lung metastases 2 (8%) 1 (7%) 3 (8%)
Procedure
Exploration only 2 (8%) 2 (14%) 4 (10%)
Pneumonectomy 0 (0%) 2 (14%) 2 (5%)
Lobectomy 18 (72%) 7 (50%) 19 (64%)
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sity score at the 30 day follow-up (2.6) and took the upper
75th centile of the standard deviation (1.63). We assumed
a minimum, clinically significant difference of 25%, i.e.,
that BPI scores will be 25% lower in the acupuncture
group compared to placebo. This gives a hypothesized
score in the control group close to 3.6. This is approxi-
mately equivalent to the expected incidence of moderate
or severe pain (defined as pain score = 4) being 20% in the
acupuncture group and 40% in controls. With a 5% alpha
and a power of 80%, 52 evaluable patients per group are
required. Allowing for 25% drop-out, we anticipate accru-
ing approximately 140 patients. The Thoracic Service at
MSKCC performs an average of 550 thoracotomies annu-
ally that would meet study eligibility criteria. We would
need to accrue 13% of patients to meet our target sample
within two years, or 9% to meet accrual targets within
three years. Both targets seem highly feasible. The rand-
omized trial has been approved by our Institutional
Review Board and has been initiated The results of this
randomized trial will determine whether acupuncture
plus standard continuous epidermal or intravenous anal-
gesia is superior to standard systemic analgesia alone.
Conclusion
The rate of data completion met our predefined criterion
for determining a randomized trial to be feasible (at least
75% of patients tolerated the intervention and provided
evaluable data). This novel intervention is acceptable to
patients undergoing thoracotomy and does not interfere
with standard preoperative care. There was no evidence of
important adverse events. We are now testing the hypoth-
esis that acupuncture significantly adds to standard peri-
operative pain management in a randomized trial.
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